月桂酰阿立派唑 T14319
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
100 mg | 1259305-29-7 | ¥1,347.00 | 询底价 |
5 mg | 1259305-29-7 | ¥255.00 | 询底价 |
1 mL | 1259305-29-7 | ¥460.00 | 询底价 |
25 mg | 1259305-29-7 | ¥677.00 | 询底价 |
50 mg | 1259305-29-7 | ¥987.00 | 询底价 |
10 mg | 1259305-29-7 | ¥417.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Aripiprazole Lauroxil
描述: Aripiprazole lauroxil 是一种长效注射剂 (LAI) 的抗精神病药物,是阿立哌唑的 N-酰氧基甲基前药形式。它能够被体内酯酶裂解为 N-羟甲基阿立哌唑(月桂酸),再裂解为阿立哌唑,无毒性。
体内活性: Intravenous administration of 1.87?mg/ml Aripiprazole lauroxil bioconversion in vivo involves the formation of an intermediate,?N-hydroxymethyl aripiprazole. The?in vitro?data indicates a high bioconversion of aripiprazole lauroxil, thus, the concentration of?N-hydroxymethyl aripiprazole observed in the animals dosed with aripiprazole lauroxil is surprisingly high[1].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 8 mg/mL (12.11 mM)
关键字: schizophrenia | Aristada | inhibit | Aripiprazole Lauroxil | Inhibitor
相关产品: Brexpiprazole S-oxide D8 | Piribedil | Dihydrexidine | Sulpiride | Sertindole | Neuromedin N acetate(92169-45-4 free base) | PG 01037 dihydrochloride | 3-CPMT | Dicarbine | Fipexide
相关库: Drug Repurposing Compound Library | Anti-Neurodegenerative Disease Compound Library | Neurotransmitter Receptor Compound Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Neuronal Signaling Compound Library | Human Metabolite Library | GPCR Compound Library | Anti-Cancer Approved Drug Library | Bioactive Compound Library
月桂酰阿立派唑 T14319信息由TargetMol中国为您提供,如您想了解更多关于月桂酰阿立派唑 T14319报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途